B. Ehst, G. Han, S. Guenthner, K. Eads, and A. Jacobson, “Long-term Efficacy and Safety of Brodalumab in Patients With Psoriasis Disease Duration <10 and ≥10 Years: Analysis of Two Phase 3 Studies”, J of Skin, vol. 3, p. S25, Nov. 2019.